Glipizide Tablet, Extended Release
Product Images NDC 72162-2614

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 72162-2614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure diagram of Glipizide, showing the molecular framework including nitrogen-containing rings, sulfonyl group, and other functional groups characteristic of the compound.*

FDA Label Image

Label (Lbl721622614)

Label for Glipizide Extended-Release Tablets, 10 mg, oral tablets. The label shows NDC 72162-2614-1 and indicates a bottle of 100 tablets. It is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Aurobindo Pharma Limited. The label includes storage instructions, a QR code for package insert, and handling precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.